Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.77NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.77NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.77NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AE.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AE.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.504NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.504NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.504NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AE.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AE.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.201NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.201NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.201NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.221NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.221NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.221NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.410NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.410NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.410NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.411NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.411NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GS.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GE.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GE.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GE.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.93NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.93NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.93NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.2.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.2.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.4.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.4.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.4.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.5.1.18NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.5.1.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.18NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GM.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GM.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GM.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.13.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.13.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.13.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used